Mixed salts of a single-entity amphetamine (ADDERALL XR)
SLI381-314A
Phase 3 small_molecule completed
Quick answer
Mixed salts of a single-entity amphetamine (ADDERALL XR) for ADHD is a Phase 3 program (small_molecule) at Takeda Pharmaceuticals International AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda Pharmaceuticals International AG
- Indication
- ADHD
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed